Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Syros Announces Publication in Cell Highlighting Gene Control as Important and Rapidly Progressing Area of Research for Yielding New Medicines to Treat Cancer

Syros Pharmaceuticals 02.09.2017

Syros Appoints Industry Leader Peter Wirth as Chair of its Board of Directors

Syros Pharmaceuticals 01.30.2017

Syros Pharmaceuticals Announces Pricing of Initial Public Offering

Syros Pharmaceuticals 06.29.2016

Syros Pharmaceuticals Presents New Data Demonstrating Significant Anti - Tumor Activity of its Selective CDK7 Inhibitor in Preclinical Models of Acute Myeloid Leukemia

Syros Pharmaceuticals 04.20.2016

Syros Pharmaceuticals Presents Data Demonstrating Significant Anti - Cancer Activity of SY - 1425 in Preclinical Models of Acute Myeloid Leukemia

Syros Pharmaceuticals 04.18.2016

Publication in Science Further Validates Importance of Gene Control Research in Yielding New Insights into Diagnosing and Treating Cancer

Syros Pharmaceuticals 03.03.2016

Syros Pharmaceuticals Closes $40 Million Preferred Stock Financing

Syros Pharmaceuticals 01.12.2016

Syros Pharmaceuticals Announces Issuance of U.S. Patents Related to Its Gene Control Drug Discovery and Development Platform

Syros Pharmaceuticals 11.10.2015

Syros Pharmaceuticals Appoints Industry Leader Marsha H. Fanucci to Its Board of Directors

Syros Pharmaceuticals 10.19.2015

FierceBiotech Names Syros Pharmaceuticals as One of Its “Fierce 15” Biotech Companies of 2015

Syros Pharmaceuticals 09.30.2015

Loading